Candidiasis of skin and nail
ICD-10 B36.2 is a billable code used to indicate a diagnosis of candidiasis of skin and nail.
Candidiasis of the skin and nails is a fungal infection caused by Candida species, most commonly Candida albicans. This condition typically manifests as red, itchy, and inflamed skin, often accompanied by a white, curd-like discharge. In the case of nail involvement, it can lead to discoloration, thickening, and separation of the nail from the nail bed. Candidiasis is more prevalent in warm, moist environments and can affect various body areas, including the groin, armpits, and under the breasts. Individuals with compromised immune systems, such as those with diabetes, HIV/AIDS, or those undergoing immunosuppressive therapy, are at a higher risk for developing candidiasis. Diagnosis is primarily clinical, supported by laboratory tests such as KOH preparation or culture. Treatment typically involves topical antifungal agents like clotrimazole or miconazole, and in more severe cases, systemic antifungals such as fluconazole may be necessary. Proper hygiene and moisture control are crucial in preventing recurrence.
Detailed descriptions of lesions, treatment plans, and follow-up care.
Patients presenting with skin rashes, nail dystrophies, or recurrent infections.
Ensure thorough documentation of the patient's history and any underlying conditions.
Comprehensive patient history, including immunocompromised status and previous infections.
Patients with recurrent candidiasis or those undergoing treatment for other infections.
Document any systemic antifungal treatments and their outcomes.
Used when a patient with nail candidiasis requires debridement due to severe infection.
Document the extent of nail involvement and the reason for debridement.
Dermatologists should note any underlying conditions that may affect healing.
Common symptoms include redness, itching, and inflammation of the skin, as well as nail discoloration, thickening, and separation from the nail bed.
